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Background: Traumatic brain injury is a major cause of mortality and morbidity worldwide. It can be worsened
by secondary injury particularly with hypoxia or hypotension. Current prehospital guidelines emphasise regular
measurement of peripheral oxygen saturation and blood pressure but there is no monitor in use to provide direct
information relating to blood flow or oxygen delivery to the brain tissue. This prospective cohort study will assess the
utility of near-infrared spectroscopy monitoring in prehospital medicine in demonstrating injury, pathophysiology and
associations with long-term functional outcomes.
Methods/design: A prospective cohort study will be conducted in prehospital services where physician/paramedic
teams respond rapidly to patients suffering significant traumatic injuries. A study observer accompanying the clinical
team will apply non-invasive near-infrared spectroscopy tissue oximetry using a Nonin EQUANOX 7610 Regional Oximetry
monitor (TM Nonin Medical, Inc.). This will be applied to patients with traumatic injuries less than 30 minutes old requiring
transport. Measurements will be taken at two sites on the forehead and one on the forearm. Clinical teams will
be blinded to all monitoring values. Near-infrared spectroscopy tissue oximetry parameters of oxyhaemoglobin
%, deoxyhaemoglobin%, total tissue haemoglobin index and regional oxygen saturation will be recorded.
Separate statistical analysis relating to time spent with cerebral regional oxygen saturation values < 45% and
time series analysis will be performed to demonstrate associations with acute phase outcomes including injuries
seen on cerebral imaging, and long-term functional outcomes measured by Glasgow Outcome Score and
Extended Glasgow Outcome Score will then be undertaken.
Discussion: This prospective cohort study will demonstrate associations evident from the earliest stages of
prehospital treatment between near-infrared spectroscopy tissue oximetry values and both acute and long-term
outcomes of patients suffering traumatic injuries. This may provide the basis for future interventional studies
utilising near-infrared spectroscopy tissue oximetry to guide prehospital trauma care.
Trial registration: This trial is registered with the Australian and New Zealand Clinical Trials Registry. The
registration number is ACTRN12611001124921.
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Traumatic brain injury (TBI) is a significant cause of
death and severe disability [1]. Estimates suggest that
long term costs of caring for people with moderate and
severe TBI add $8.6 billion to health spending per year
in Australia [2]. Despite advances in hospital care of pa-
tients with TBI, minimal improvements in outcome have
been evident over the last twenty years [1].
In the setting of TBI, it is not only the initial injury that
is responsible for patient outcome. After the initial insult,
the brain is susceptible to further damage if normal physio-
logic conditions are not restored. Such insults include low
blood pressure or hypoxia [3,4]. The primacy of hypoxia
and hypotension in the debate has guided the development
of consensus guidelines for prehospital management of pa-
tients with TBI with an emphasis on regular blood pressure
measurements and checking oxygen saturations [5]. How-
ever, having this knowledge to guide monitoring care has
not resulted in significant changes to patient outcomes.
Peripheral measurements such as non-invasive blood
pressure and pulse oximetry remain relatively crude
measurements distant to the tissue of most interest; the
brain itself. Additional monitoring options that have be-
come available in the hospital such as jugular venous
bulb oximetry, direct tissue oximetry and intracranial
pressure measurement are not appropriate to the pre-
hospital environment [6-8]. In the New South Wales
metropolitan setting, the time spent in the prehospital
treatment phase before reaching a trauma centre aver-
ages over one hour [9]. This represents a significant
period of vulnerable time where monitoring information
relevant directly to cerebral tissue is absent.
Near-infrared spectroscopy (NIRS) tissue oximetry was
first described in 1977 and is now used within hospitals [10].
It uses light in the near-infrared spectrum (700–1300 nm)
and relies on the interaction of these wavelengths with tissue
chromophores to derive information about oxygenated
blood in the monitored region. Commercial devices use
reflectance spectroscopy. The light is shone into tissues
from an emitting light source within a self-adherent probe
at the skin. Light entering the tissues interacts with chro-
mophores, with the degree of absorption and scattering
specific to the near-infrared wavelength employed. The
fraction of transmitted light that returns to the surface is
detected within the same probe, with a standard separ-
ation between the initial light source and the detector.
Utilising known characteristics of the interaction of
particular near-infrared wavelengths with biological tis-
sues allows the calculation of a number of parameters:
 Oxyhaemoglobin%, (HbO2) a measure of
haemoglobin carrying oxygen through the tissues;
 Deoxyhaemoglobin% (HbD), a measure of
haemoglobin present but not carrying oxygen; Total tissue haemoglobin index (HbT) – an index
(expressed in g/dL) corresponding with blood
volume and flow within the sampled tissue; and,
 Regional oxygen saturation (StO2%), providing a
measure of the balance of oxygen delivery and
utilisation in the tissue under the probe as it adjusts
for the influence of chromophores other than oxy- and
deoxyhaemoglobin as well as the adjustment for the
proportional amounts of arterial and venous blood in
the sampled area.
Recent monitors display improved accuracy and time
resolution and are therefore spreading into a variety of
clinical areas including detection of silent ischaemia in
subarachnoid haemorrhage, coronary artery bypass graft-
ing, aortic arch surgery, paediatric cardiac surgery and
carotid endarterectomy [11-15].
NIRS oximetry has been utilised in head injury pa-
tients although application of the monitor has gener-
ally occurred hours after the initial injury. Early work
with NIRS tissue oximetry has suggested that it may
provide useful information in detecting intracranial
haematomas and correlation with direct tissue oxim-
etry. To date this work has been entirely hospital-
based [16-19].
A further relatively recent development in the use of NIRS
oximetry is the ability to use novel analysis techniques to as-
sess dynamic factors such as cerebrovascular autoregulation.
Various approaches such as coherence analysis of spectral
waveforms and floating correlation analysis of moving value
windows have been described in the assessment of vascular
reactivity in subarachnoid haemorrhage, traumatic brain in-
jury, paediatric cardiac surgery and extracorporeal mem-
brane oxygenation [20-24]. Examples of this analysis rely on
examination of the trends and patterns seen in the haemo-
globin index (HbT) rather than analysis of absolute values of
either HbT or rSO2.
This study builds on earlier work demonstrating the
possibility of obtaining NIRS oximetry monitoring values
in the prehospital and transport environments [25]. It
will assess the utility of prehospital NIRS oximetry in
the monitoring of patients with TBI.
Study plan
The hypothesis is that NIRS tissue oximetry can provide dir-
ect real-time cerebral physiological data that provides an
insight into rapidly developing brain pathology in TBI and
its management, as well as early associations with long-term
outcomes. Three aims will be delivered to achieve this:1. To establish methods of analysing the NIRS tissue
oximetry monitoring parameter time series that
correspond with evolving pathology in the TBI.
Figure 1 Cerebral oximetry probes applied to a volunteer
during helicopter transport as part of feasibility testing.
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oximetry monitoring parameters and acute
pathology in patients with TBI.
3. To establish the association between NIRS tissue
oximetry monitoring parameters and the long-term
recovery of patients after TBI, as assessed at follow-up
to 12 months.
This research will therefore be conducted in a prehos-
pital setting, providing early monitoring data in patients
likely to have TBI with a plan for subsequent follow-up
data collection to examine both acute and long-term
outcomes. Novel analysis methods as featured in Aim 1
will provide better options for demonstrating the associ-
ations described in aims 2 and 3.
Study design and setting
This is a prospective cohort study.
This research will be conducted in a prehospital
emergency medical service employing a physician-
paramedic model of care to deliver rapid response
trauma care and employing both rotary-wing and road
transport modalities. The clinical team is capable of
providing advanced life support, anaesthesia, intub-
ation and ventilation, blood transfusion and peripheral
haemorrhage control manoeuvres along with other
critical care interventions at the scene of the accident
or during patient transport.
Inclusion and exclusion criteria
All patients where patient contact is within 30 minutes
of the injury and who are being transported to the
trauma centre by the prehospital clinical team will be
considered for inclusion. Exclusion criteria include:
– Patients < 1 year old and > 70 years old.
– Patients with pre-existing neurological disease or
neurological trauma.
– Patients with no mechanism for trauma,
(e.g. drowning, medical complaints);
– Patients with forehead haematomas or lacerations
precluding NIRS probe application;
– Patients where follow-up consent is not later
obtained from the patient or family.
Exclusion criteria may be apparent at the accident
scene or may be applied upon the collection of add-
itional information that reveals the patient meets exclu-
sion criteria.
Monitor application
For the purposes of this research, NIRS cerebral oxim-
etry will be applied by a trained researcher as soon aspossible after arrival at the patient to ensure the clinical
team are able to undertake their standard approach to
care. The monitor employed will be a Nonin EQUA-
NOX 7610 Regional Oximetry monitor (TM Nonin
Medical, Inc.). This trained observer will apply monitor-
ing probes bifrontally to the forehead of patients and to
a peripheral reference site on the forearm (Figure 1).
Monitoring will be commenced within a time frame of
30 minutes after the initial injury. The monitoring
screen will only show that data capture is proceeding
with warning signals if there are issues with sensor con-
tact or signal quality. The EQUANOX 7610 monitor will
continuously store the NIRS monitoring data. NIRS
monitoring will cease on patient handover at the receiv-
ing hospital.
Data collection
Data collected by the research nurse, who will be
blinded to NIRS monitoring information, will include
patient demographics already recorded as a routine
(available at the time of the injury) and via hospital
follow-up. Trauma incident data including incident time
and total prehospital duration will also be recorded in
initial case documentation.
NIRS monitoring data
Each NIRS oximetry probe will continually produce 4
streams of data: StO2; HbT; HbO2; and HbD with values
recorded every 4 seconds. Standard clinical monitoring
will be recorded at the same time as the NIRS oximetry
data captured by the EQUANOX device. This will in-
clude peripheral pulse oximetry, end-tidal capnography
(where indicated for patient care), heart rate and non-
invasive blood pressure and will be updated on the rec-
ord every ten seconds. This general observations data
will be time-matched to the NIRS oximetry monitoring
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analysis, particularly in the signals analysis related to
Aim 1. Clinically relevant information such as any degree
of prehospital hypoxia or hypotension will therefore
be time-matched to the NIRS oximetry monitoring
data.Patient event and intervention marking
The data capture system for the NIRS oximetry monitor
will also facilitate real-time marking of clinical events
and interventions by the study observer. This will in-
clude real-time marking of bag-mask ventilation, cardio-
pulmonary resuscitation, anaesthesia with thiopentone,
anaesthesia with ketamine, intubation, institution of
mechanical ventilation, administration of vasopressor,
transfusion, administration of hypertonic saline and seiz-
ure activity. Study observers will also have the ability to
mark other potential events deemed clinically relevant.
This will provide accurate information on interventions
undertaken in a manner that is time-matched to the
NIRS oximetry monitoring data. Event marking will be
combined with NIRS oximetry monitoring data and gen-
eral observations monitoring to allow reporting of stand-
ard interventions and care as previously described [26].
Patient general observations monitoring information and
management and intervention details will be presented
in conjunction with all outcome data.Early phase outcome data
Patient outcome and follow-up data related to initial
findings and hospital stay will be obtained from the hos-
pital by the trial research nurse at a time beyond 30 days
from the injury and include: (1) Injury Severity Score
(ISS) and Abbreviated Injury Scores (AIS) for each body
region [27,28]; (2) injuries identified on independent re-
view of first cerebral imaging by computerised tomog-
raphy (CT) or magnetic resonance imaging (MRI); (3)
24 hour and 30 day mortality; (4) survival to hospital
discharge; and, (5) length of intensive care unit (ICU)
stay including number of ventilator days.Long-term outcomes
Follow-up by the research nurse will be undertaken via
phone interview with the patient or appropriately iden-
tified relative as previously described [29] to assess and
record (1) Glasgow Outcome Scale score (GOS) and
Extended Glasgow Outcome Scale (EGOS) score at 6
and 12 months post injury [30]; (2) Disability Rating
Scale (DRS) at 6 and 12 months post injury [31] and,
(3) Care and Needs Scale (CANS) at 6 and 12 months
post injury [32].Power analysis
Pre-existing datasets showing the relationship between
prehospital NIRS oximetry values and patient injury out-
comes in the context of TBI are lacking. To answer Aim
1, a sample size of 242 subjects with severe TBI will pro-
vide 90% power to detect correlation of 0.22 or higher
[33] in a 2-sided 0.05 level test of the null hypothesis of
no correlation between NIRS cerebral oximetry values
and admission Glasgow Coma Score (GCS) adjusting for
29 (approximately 12%) unsuccessful NIRS monitoring
data collection attempts (25) in a time series based re-
gression analysis. CareFlight’s historical mission database
indicates 1210 total recruits will be required to incorpor-
ate 242 subjects with severe TBI.
To address Aims 2 and 3, the same number of subjects
will be enough to show an incidence of EGOS 4 at six
months post-injury of 56% (95%CI 49% to 63%) and
demonstrate a clinically important change in EGOS of 1
point associated with NIRS cerebral oximetry value at
80% power to detect a Cochrane-Armitage test for trend
in EGOS groups (30% deceased, 20% poor neurological
outcome and 50% good neurological outcome) at signifi-
cance level of 0.05. The expected proportion of EGOS
groups have been taken from the subject characteristics
from the Head Injury Retrieval Trial [data under ana-
lysis] [29].
As for validation of the model for Aims 2 and 3, we
will internally validate the models using bootstrapping
methods on 1000 samples.
Subgroups for analysis and reporting
Some patients, particularly those with more severe in-
juries and those of a different age, are more likely to
have monitor findings indicating strong associations
with outcomes and are therefore of particular interest.
Subgroup analysis will be undertaken on patients with
severe TBI (first GCS ≤ 12 and Abbreviated Injury
Score (Head) ≥ 3), severe traumatic injury (ISS > 15),
and paediatric patients (age < 16 years).
Data analysis
Novel analysis methodology to address aim 1: establishing
new analysis methods
A variety of approaches to signals analysis as commonly
utilised in biomedical engineering fields will be under-
taken. These will include (but not be limited to) time
series analysis and pattern recognition and classification
undertaken on all monitoring value streams (StO2, HbT,
HbO2 and HbD) for each of the cerebral probes separ-
ately, and the peripheral reference probe. These may be
matched to ancillary signals including peripheral oxygen
saturation and electrocardiograph parameters (RR and
QT intervals, RR variability). Comparison may also be
made between NIRS oximetry probes. Control group
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be the reference group for analysis of “standard” signals
analysis patterns comparisons.
Novel analysis methods applied to acute phase outcomes
Analyses undertaken in this way will be tested against the
following changes seen on cerebral imaging: no intracra-
nial pathology, intracerebral lesions (haemorrhage or con-
tusion), subdural haematoma, extradural haematoma,
traumatic subarachnoid haemorrhage and diffuse injury.
Comparison to 24 hour and 30 day mortality will also be
undertaken. Control group patients with traumatic injuries
but no brain injury will provide data for analysis of “stand-
ard” signals analysis patterns.
Novel analysis methods applied to long-term outcomes
Analysis as described above will also be assessed
against long-term outcomes as grouped by EGOS
score at 6 and 12 months as described in the statistical
analysis (EGOS < 2, 2–4 and 5–8).
Outcomes for aim 1
Exploration of a variety of signals analysis approaches to
analyse NIRS cerebral oximetry is an explicit component
of the study design. Establishment of useful approaches
of this nature offer the greatest chance to develop real-
time non-invasive monitoring that reflects the under-
lying pathology that is developing. This has implications
not just for future management relevant to all prehospi-
tal practitioners but may inform better approaches to
utilising NIRS cerebral oximetry in hospital care.
Statistical analysis for aim 2: associations of nirs tissue
oximetry with acute phase outcomes
The area under the curve for cerebral oximetry value ≤
45% (minutes x desaturation points ≤ 45%) will be used
as an independent variable for statistical analyses as de-
scribed previously [34]. Patients with one or more epi-
sodes of cerebral oximetry value ≤ 45% for 1 minute will
be classified as experiencing a decline in cerebral oxygen
saturation.
We will define 3 NIRS cerebral oximetry patient groups:
(1) NIRS 1 (cerebral oximetry values remain > 45% i.e.
area under the curve = 0 min%).
(2) NIRS 2 (cerebral oximetry values ≤ 45% for > 0 min
up to the median area under the curve for cerebral
oximetry value ≤ 45% to be determined).
(3) NIRS 3 (cerebral oximetry values ≤ 45% for more
than the median area under the curve for cerebral
oximetry value ≤ 45% to be determined).
The total duration (minutes) of StO2 ≤ 45%, longest
duration (minutes)StO2 ≤ 45%, minimum and average StO2 will be de-
rived for each patient. These variables will be compared
between NIRS 1, NIRS 2 and NIRS 3 groups using
Kruskal-Wallis analysis of variance to check the validity
of this grouping.
A chi-square test will be used to assess the association
between cerebral oximetry values by comparing patients
in each of the above groups in their association with the
following injury patterns on cerebral imaging: no intra-
cranial pathology, intracerebral lesions present, subdural
haematoma, extradural haematoma, traumatic subarach-
noid haemorrhage and diffuse injury. The same analysis
will also be repeated to establish associations with
24 hour and 30-day mortality and survival to discharge.
In the multivariate analysis, an ordinal logistic regres-
sion under a proportional odds model with NIRS 1 as
the reference group will be used with the six types of
injury on cerebral imaging listed above included as an
independent variable after adjusting for ISS, age, sex
and other covariates (mean arterial pressure, first re-
corded GCS, peripheral oximetry, end-tidal CO2, HbT)
in a stepwise fashion. A score test will be used to verify
the proportional odds assumption in the final model.
The unadjusted and adjusted odds ratios and 95% con-
fidence intervals will be reported. Significance will be
set at P < 0.05.
Outcomes for aim 2
This analysis will establish the associations between
NIRS cerebral oximetry values and types of brain injury.
This will underpin new approaches to interpretation of
NIRS tissue oximetry values to provide real-time infor-
mation corresponding with the development of path-
ology underlying the cerebral oximetry probes, be that
swelling and oedema or acute development of blood
collections.
Statistical analysis for aim 3: associations with long-term
outcomes
Utilising the same groupings for NIRS tissue oximetry
(NIRS 1 through 3), associations with EGOS (grouped
into EGOS < 2, 2–4 and 5–8), GOS and CANS will be
tested with the same multivariate analyses and ordinal
logistic regression approach described above. This will
include adjustment for ISS, age, sex and other covariates.
For validation of the model for Aims 2 and 3, we will
internally validate the models using bootstrapping
methods on 1000 samples. All data analysis will be per-
formed using SPSS version 21 and STATA 13.1 soft-
ware (StataCorp, College Station, TX).
Outcomes for aim 3
This analysis will establish simple associations between
NIRS cerebral oximetry values and the subsequent long-
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would potentially allow early identification of patients
with more severe injuries to optimise early intervention
and engagement of rehabilitation services.
Research ethics
This project has lead ethics approval from the Sydney
Children’s Hospital Network Human Research Ethics
Committee (reference 11/SCHN/212). An initial waiver
for consent to data collection has been provided as de-
lays to patient care caused by an upfront process would
be inappropriate. During the follow-up phase, consent
will be obtained from the patient or, where more appro-
priate, a family member to undertake ongoing data col-
lection and analysis. A Data Safety and Monitoring
Committee has also been empanelled. This group will
utilise reports from the investigators to confirm that
there are no delays or alterations to patient care once
the study is under way. Rigorous data security will be
maintained for 15 years or, in the case of paediatric pa-
tients, until the subject reaches the age of 25.
Discussion
The ideal prehospital monitoring technology for the pa-
tient with TBI would be a non-invasive monitor that
provides real-time information regarding conditions in
the brain tissue. Appropriately validated this would pro-
vide the treating clinician as to what the organ needs at
that moment to decrease the size of acute injuries and
enhance patient recovery in the long term.
NIRS tissue oximetry may provide such an option. It is
easy to apply without delay. In the hospital setting good
sensitivity has already been demonstrated for detection
of intracranial haematomas preoperatively when corre-
lated with CT or MRI [16-18]. Correlation with invasive
monitoring has shown mixed results. Increased length of
time with an StO2 below 60% has been associated with
intracranial hypertension, decreased cerebral perfusion
pressure and mortality in a small observational study
[33]. In this study, monitoring was applied at the time of
cerebral imaging, but this occurred anywhere up to
twelve hours after the initial insult.
Research comparing regional oxygen saturation to dir-
ect, invasive brain tissue oxygen tension in 22 patients
for the 16 hours after severe traumatic brain injury
showed moderate accuracy in detecting severe brain
hypoxia with area under curve on receiver-operating
characteristic curve of 0.82 (with a likelihood ratio of a
positive test of 5.3) but a poor ability to detect moderate
hypoxia [19]. In this study patients had already passed
the phase where they required resuscitation, and had all
received neurosurgery. As a result many hours had
passed and the subsequent monitoring and analysis is
not reflective of early stage pathology.The prehospital context is precisely about these early
stages. Presently available research suggests there is good
reason to be interested in cerebral tissue oximetry for
this clinical setting, but cannot be considered as know-
ledge that can be directly transferred. This research will
generate new evidence about the potential utility of
NIRS tissue oximetry in the prehospital environment. It
will be directly related to the prehospital treatment
phase with the ability to include recording of general
prehospital observations and patient interventions in-
cluding transfusions and standardised reporting of pre-
hospital airway management [26]. Many of the initial
concerns relating to potential interference with cere-
bral tissue oximetry measurements, including varying
venous and arterial compartments in the sampled tis-
sue, oedema, bruising and jaundice have proven to be
surmountable with probe placement and looking at
monitoring values over time [35]. As obtaining moni-
toring values has been demonstrated to be feasible in
the prehospital setting, there is no reason to believe
that this technology cannot be employed in this new
clinical context [25].
This study design will facilitate the acquisition of new
knowledge directly relevant to prehospital medicine. The
data analysis plan will explore associations with broad
groupings of regional oxygen saturations as well as more
dynamic measures of changing measurements over time
through varying approaches to time series analysis.
Moreover it will address both early and evolving patho-
physiology by exploring associations with findings on
cerebral imaging, as well as long-term functional out-
comes that may be associated with early cerebral tissue
oximetry values. Demonstrating such associations could
both deepen our understanding of early pathophysiology of
TBI, and provide the basis of future research where clinical
interventions are guided by tissue oximetry values.
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